Long-Term Health Risks for Women with Gestational Diabetes
Primary Risk: Type 2 Diabetes
- Women with gestational diabetes have a 10-fold increased risk of developing type 2 diabetes compared to women without gestational diabetes, with a lifetime risk of 50-60% 1
- The risk of developing type 2 diabetes follows a linear progression throughout life, with approximately 20% at 10 years, 30% at 20 years, 40% at 30 years, 50% at 40 years, and 60% at 50 years after the gestational diabetes pregnancy 1
- Published studies demonstrate that 35-60% of women develop type 2 diabetes within 10 years after gestational diabetes 2
Cardiovascular Disease Risk
- Women with gestational diabetes share characteristics with metabolic syndrome, including glucose intolerance, insulin resistance, central obesity, elevated triglycerides, and low HDL cholesterol 2
- Evidence suggests that short-term endothelial dysfunction during late pregnancy manifests as transient hypertension, with long-term endothelial dysfunction associated with chronic hypertension and cardiovascular disease 2
- Chronic insulin resistance may produce chronic inflammation, adversely affecting vascular reactivity and atherogenesis 2
Additional Long-Term Risks
- Women with gestational diabetes have an increased risk of impaired glucose tolerance and type 1 diabetes, with markers of islet cell-directed autoimmunity associated with increased risk 2
- There is an increased risk of chronic hypertension later in life 2
Critical Follow-Up Requirements
- The American College of Obstetricians and Gynecologists recommends performing a 75-g oral glucose tolerance test at 4-12 weeks after delivery 1
- Fasting plasma glucose alone has insufficient sensitivity for diagnosing impaired glucose tolerance or type 2 diabetes postpartum, emphasizing the need for oral glucose tolerance testing 2
- Annual screening with A1C or fasting plasma glucose, and triennial 75-g oral glucose tolerance testing, are recommended for women with a history of gestational diabetes 1
Evidence-Based Prevention Strategies
- Intensive lifestyle intervention can reduce progression to diabetes by 35% over 10 years, with a number needed to treat of 5-6 individuals to prevent one case of diabetes over 3 years 1
- Metformin can reduce progression to diabetes by 40% over 10 years in women with prediabetes and a history of gestational diabetes, with a number needed to treat of 5-6 individuals to prevent one case of diabetes over 3 years 1
- Thiazolidinediones have shown efficacy in preventing progression from impaired glucose tolerance to diabetes 2
Important Clinical Pitfalls
- Relying solely on fasting glucose misses the majority of women with glucose intolerance 2
- Progestin-only oral contraceptives and depo medroxyprogesterone acetate are associated with a 2- to 3-fold increase in diabetes risk in Latino populations of breastfeeding women 2
- Pregnancy planning should include evaluation of glucose tolerance, and if abnormal, treatment of hyperglycemia before discontinuation of contraception 2